Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CD39L1/ENTPD2 Antibody, R&D Systems™

Sheep Polyclonal Antibody
Supplier: R&D Systems AF6087SP
This item is not returnable.
View return policy
Description
CD39L1/ENTPD2 Polyclonal specifically detects CD39L1/ENTPD2 in Human samples. It is validated for Western Blot, Immunoprecipitation.Specifications
CD39L1/ENTPD2 | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD39 antigen-like 1, CD39L1, CD39L1NTPDase 2, CD39-like-1, EC 3.6.1, EC 3.6.1.-, EC 3.6.1.5, Ecto-ATP diphosphohydrolase 2, Ecto-ATPase, Ecto-ATPase 2, Ecto-ATPDase 2, ectonucleoside triphosphate diphosphohydrolase 2, ENTPD2, NTPD2, NTPDase 2, NTPDase-2 | |
Sheep | |
Affinity Purified | |
RUO | |
954 | |
Sterile PBS to a final concentration of 0.2 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Immunoprecipitation | |
LYOPH | |
Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL | |
Q9Y5L3 | |
ENTPD2 | |
Chinese hamster ovary cell line CHO-derived recombinant human CD39L1/ENTPD2 Thr29-Asp460 Accession # Q9Y5L3 | |
25 μg | |
Primary | |
Detects human CD39L1 in direct ELISAs and Western blots. In direct ELISAs, approximately 40% cross-reactivity with recombinant mouse CD39L1 and less than 1% cross-reactivity with recombinant human (rh) CD39L2, rhCD39L3, and rhCD39L4 is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction